Malliga R Iyer1, Richard B Rothman, Christina M Dersch, Arthur E Jacobson, Kenner C Rice. 1. Drug Design and Synthesis Section, Chemical Biology Research Branch, National Institute on Drug Abuse and The National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892-9415, USA.
Abstract
A series of N-methyl rac-cis-4a-aralkyl- and alkyl-substituted-1,2,3,4,4a,9a-hexahydrobenzofuro[2,3-c]pyridin-6-ols have been prepared (2a-l) using a simple previously designed synthetic route, in order to find a ligand that would interact with both μ- and δ-opioid receptors. A C4a-phenethyl derivative 2a, was found to have modest receptor affinity both at μ- (K(i)=60 nM) and δ-opioid receptors (K(i)=64 nM). The N-methyl substituent of 2a and that of other ligands in the series was then modified to obtain compounds with different N-substituents that might provide higher affinity at both receptors. A number of compounds differently substituted at C4a and N were synthesized and evaluated. Binding studies and functional assays revealed a moderately selective δ-antagonist (2l), selective μ-δ antagonists (3d, 3g), and a μ-κ antagonist (3f). Published by Elsevier Ltd.
A series of n class="Chemical">N-methyl rac-cis-4a-aralkyl- and alkyl-substituted-1,2,3,4,4a,9a-hexahydrobenzofuro[2,3-c]pyridin-6-ols have been prepared (2a-l) using a simple previously designed synthetic route, in order to find a ligand that would interact with both μ- and δ-opioid receptors. A C4a-phenethyl derivative 2a, was found to have modest receptor affinity both at μ- (K(i)=60 nM) and δ-opioid receptors (K(i)=64 nM). The N-methyl substituent of 2a and that of other ligands in the series was then modified to obtain compounds with different N-substituents that might provide higher affinity at both receptors. A number of compounds differently substituted at C4a and N were synthesized and evaluated. Binding studies and functional assays revealed a moderately selective δ-antagonist (2l), selective μ-δ antagonists (3d, 3g), and a μ-κ antagonist (3f). Published by Elsevier Ltd.
Authors: Gianfranco Fontana; Giuseppe Savona; Benjamín Rodríguez; Christina M Dersch; Richard B Rothman; Thomas E Prisinzano Journal: Tetrahedron Date: 2008-12-20 Impact factor: 2.457
Authors: Malliga R Iyer; Yong Sok Lee; Jeffrey R Deschamps; Christina M Dersch; Richard B Rothman; Arthur E Jacobson; Kenner C Rice Journal: Eur J Med Chem Date: 2012-01-20 Impact factor: 6.514
Authors: Fuying Li; Jason A Deck; Christina M Dersch; Richard B Rothman; Jeffrey R Deschamps; Arthur E Jacobson; Kenner C Rice Journal: Eur J Med Chem Date: 2012-10-30 Impact factor: 6.514
Authors: Subramaniam Ananthan; Surendra K Saini; Christina M Dersch; Heng Xu; Nicholas McGlinchey; Denise Giuvelis; Edward J Bilsky; Richard B Rothman Journal: J Med Chem Date: 2012-09-27 Impact factor: 7.446
Authors: A J Hutchison; R de Jesus; M Williams; J P Simke; R F Neale; R H Jackson; F Ambrose; B J Barbaz; M A Sills Journal: J Med Chem Date: 1989-09 Impact factor: 7.446
Authors: Malliga R Iyer; Yong Sok Lee; Jeffrey R Deschamps; Richard B Rothman; Christina M Dersch; Arthur E Jacobson; Kenner C Rice Journal: Bioorg Med Chem Date: 2009-11-18 Impact factor: 3.641
Authors: Muneaki Kurimura; Hehua Liu; Agnieszka Sulima; Akihiro Hashimoto; Anna K Przybyl; Etsuo Ohshima; Shinichi Kodato; Jeffrey R Deschamps; Christina M Dersch; Richard B Rothman; Yong Sok Lee; Arthur E Jacobson; Kenner C Rice Journal: J Med Chem Date: 2008-12-25 Impact factor: 7.446
Authors: Malliga R Iyer; Richard B Rothman; Christina M Dersch; Arthur E Jacobson; Kenner C Rice Journal: Eur J Med Chem Date: 2015-01-13 Impact factor: 6.514